Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1484Neoplasms 1100Carcinoma, Non-Small-Cell Lung 915Prostatic Neoplasms 800Multiple Myeloma 584Colorectal Neoplasms 533Leukemia, Myeloid, Acute 500Lung Neoplasms 489Lymphoma 454Melanoma 452Neoplasm Metastasis 450Lymphoma, Non-Hodgkin 415Leukemia 407Leukemia, Lymphocytic, Chronic, B-Cell 366Ovarian Neoplasms 356Pancreatic Neoplasms 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 331Recurrence 315Lymphoma, Follicular 297Head and Neck Neoplasms 297Myelodysplastic Syndromes 280Carcinoma, Renal Cell 272Glioblastoma 266Brain Neoplasms 265Hodgkin Disease 260Lymphoma, Large B-Cell, Diffuse 255Carcinoma, Hepatocellular 241Lymphoma, Mantle-Cell 219Squamous Cell Carcinoma of Head and Neck 214Stomach Neoplasms 208

Interventions

Saline Solution 1Lidocaine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Has results × Scleroderma, Localized × Clear all
NCT03630198 2021-03-11

Pain Outcomes Following Intralesional Corticosteroid Injections

Vanderbilt University Medical Center

Phase 4 Completed
31 enrolled 6 charts

Acne Vulgaris, Alopecia Areata, Dermoid Cyst, Keloid, Keratoacanthoma, Lichen Planus, Neurodermatitis, Scleroderma, Localized, Granuloma Annulare, Cicatrix, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡